Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia
about
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategiesAdvances in the Treatment of Ischemic Diseases by Mesenchymal Stem CellsHoming and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?Mesenchymal stem cells migration homing and trackingImmunobiology of mesenchymal stem cellsTherapeutics with SPION-labeled stem cells for the main diseases related to brain aging: a systematic reviewCell based therapies for ischemic stroke: from basic science to bedsideBiodistribution, migration and homing of systemically applied mesenchymal stem/stromal cellsCell tracking technologies for acute ischemic brain injuryDeveloping Cellular Therapies for StrokeLabel-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic StrokeTargeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrierMRI stem cell tracking for therapy in experimental cerebral ischemia.Magnetic resonance imaging and cell-based neurorestorative therapy after brain injury.In vivo neural stem cell imaging: current modalities and future directions.Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model.The effect of adipose tissue-derived stem cells in a middle cerebral artery occlusion stroke model depends on their engraftment rateFeasibility and Efficacy of Intra-Arterial Administration of Mesenchymal Stem Cells in an Animal Model of Double Toxin-Induced Multiple System Atrophy.Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study.Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokesNeural repair and neuroprotection with stem cells in ischemic stroke.Stem cell tracking by nanotechnologiesAdvances in progenitor cell therapy using scaffolding constructs for central nervous system injury.Modern approaches to pediatric brain injury therapy.Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging propertiesDirect intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB-mediated increase in interleukin-6 productionTrophic factors and stem cells for promoting recovery in stroke.Tracking stem cells for cellular therapy in stroke.A randomized trial of mesenchymal stem cells in multiple system atrophy.Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.Effect of labeling with iron oxide particles or nanodiamonds on the functionality of adipose-derived mesenchymal stem cellsLong-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells.In vivo MR imaging of intraarterially delivered magnetically labeled mesenchymal stem cells in a canine stroke modelOptimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imagingLong-term magnetic resonance imaging of stem cells in neonatal ischemic injuryHuman glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination.MR monitoring of minimally invasive delivery of mesenchymal stem cells into the porcine intervertebral disc.Serial transplantation and long-term engraftment of intra-arterially delivered clonally derived mesenchymal stem cells to injured bone marrow.Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesMesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model.
P2860
Q26740083-B0E94B10-C127-49FA-9692-7EF5059D510AQ26746977-727F1A23-EB23-492C-B0B2-3168D29A7FC2Q26750318-F8034C6D-545E-4EDF-B970-DD356BAC834FQ27003059-B2C37F32-AA64-4DD7-8229-2B3B82DC3E24Q27004487-EBB3363B-DA89-4996-85A2-330C5A570AF4Q27008479-7D537415-6207-4DA9-96A2-80DE9AAD6819Q27025754-1446F2E9-6ED9-4E1B-8E82-D2AAA3BBDE4BQ28069791-323E0033-0529-4C73-B566-944AE09F531AQ28084529-374F60A0-A4D2-430E-ABF2-D89BD8DDBAE9Q28087451-174A97FC-726B-4148-A36D-2F049D4EEF30Q28829493-21784AEC-47CE-4499-BE3D-07E2AB468839Q30472787-9A257321-C954-42BA-A629-2415EEC4D754Q30712193-CC4AFE74-48A0-4B40-BA0A-3F9D917F46E1Q31058941-A995BD89-98BB-4701-AFCB-A362A8F77738Q33519142-034BDED1-04CA-4F12-8155-73E07EBA85EBQ33577748-5E70F7E4-64E7-43D3-8975-B4DA7F11DF39Q33608949-9A636ABE-B5A4-405E-8A30-1922D6134DE0Q33722037-E4B90652-0A67-4EBE-BE65-52291C5B37C9Q33748370-2D771CC3-2B66-45FC-9E13-8046474DCA8AQ33771764-1E369D98-556A-4EB4-A68C-C87A65A9FEABQ33772112-20822CB6-54D1-4820-AD66-C08A66E644D2Q33848165-E9A1ADA2-C696-487C-A9CC-81E7862CDB1FQ33870573-4DF0A9B9-24AE-49E9-9BF3-5F1A3DA75889Q33870603-9C5374F1-827F-4E47-A6A0-4491EB91AFFBQ33872679-F56A41F0-241C-4024-AC62-CEA6BEDA079BQ33938085-76C56B33-1401-40D3-B7B2-0CBEAE0E16F0Q34240109-A5125074-440A-434B-B5E5-F4EB57923007Q34263640-538AA446-7CF5-41D0-8456-D9E426AEF9A3Q34290126-8157E2CD-1DD8-47BE-BAD7-2B64ED58348FQ34432396-E2664A64-F419-4D9E-853B-900A455B639EQ34542252-0C37F486-E959-4C38-BC87-863AEF9D06F2Q34544040-B9346A5D-B10E-4C52-A471-A8E00EFFDD7EQ34585929-707F8DE5-A8F3-47F7-A6C7-050A8404ADC0Q34618047-A0F260FF-D7D8-40E8-A5EC-602D7024855EQ34754264-EFBF424B-84F1-4540-88BC-F0BF6B93717EQ34821727-D00C3C57-B9C3-40B2-B909-5ACE8E3584E9Q34994864-F138F6A1-D8DA-4D66-BBAA-22444CCE0BFFQ34997877-489D7D09-C560-4BB1-B9E9-568E9A8C65D4Q35200156-F4E566D4-6343-4321-8DE0-992D52BD7FEDQ35243356-D7A8AA54-856C-4755-A5D8-C6B9EEA5AA28
P2860
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Dual-modality monitoring of ta ...... cells after transient ischemia
@ast
Dual-modality monitoring of ta ...... cells after transient ischemia
@en
Dual-modality monitoring of ta ...... ells after transient ischemia.
@nl
type
label
Dual-modality monitoring of ta ...... cells after transient ischemia
@ast
Dual-modality monitoring of ta ...... cells after transient ischemia
@en
Dual-modality monitoring of ta ...... ells after transient ischemia.
@nl
prefLabel
Dual-modality monitoring of ta ...... cells after transient ischemia
@ast
Dual-modality monitoring of ta ...... cells after transient ischemia
@en
Dual-modality monitoring of ta ...... ells after transient ischemia.
@nl
P2093
P2860
P50
P1433
P1476
Dual-modality monitoring of ta ...... cells after transient ischemia
@en
P2093
Assaf A Gilad
Dorota A Kedziorek
Jeff W M Bulte
Jesus Ruiz-Cabello
Jian Zhang
Mark F Pittenger
Randell G Young
P2860
P304
P356
10.1161/STROKEAHA.107.502047
P407
P577
2008-03-06T00:00:00Z